Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis

Archives of Disease in Childhood

Volumn 75, Issue 3, 1996, Pages 186-190

  Gianviti, A ^a,c   Trompeter, R S ^a   Barratt, T M ^a   Lythgoe, M F ^b   Dillon, M J ^a  

^a HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Henoch Schonlein purpura; Plasma exchange; Rapidly progressive glomerulonephritis; Systemic lupus erythematosus; Vasculitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE;

ADOLESCENT; ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; VASCULITIS;

EID: 0029786167     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.75.3.186     Document Type: Article

References (23)

1. Lockwood CM, Boulton-Jones JM, Lowenthal RM, Simpson IJ, Peters DK, Wilson CB. Recovery from Goodpasture's syndrome after immmunosuppressive treatment and plasmapheresis. BMJ 1975; ii: 252-4.
2. Lockwood CM, Pinching AJ, Sweny P, Rees AJ, Pussell B, Uff J. Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet 1977; i: 63-7.
3. Verrier-Jones J, Gumming RH, Bacon PA, et al. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Q J Med 1979; 192: 555-76.
4. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms and therapy. Am J Kidney Dis 1988; 6: 449-64.
5. Guillevin L, Fain O, Lhote F, et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum 1992; 35: 208-15.
6. Guillevin L, Jarrousse B, Lok C, et al. Long-term follow-up after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma-exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. J Rheumatol 1991; 18: 567-74.
7. Leaker BR, Becker GJ, Dowling JP, Kincaid-Smith PS. Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression. Clin Nephrol 1986; 25: 236-44.
8. Lewis EJ, Hunsicker LG, Shu-Ping Lan, Rohde RD, Lachin JM, for the Lupus Nephritis Collaborative Study Group. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992; 326: 1373-9.
9. Glockner WM, Sieherth HG, Wichmann HE. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study. Clin Nephrol 1988; 29: 1-8.
10. Cole E, Cattran D, Magil A, et al. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. Am J Kidney Dis 1992; 3: 261-9.
11. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991; 40: 757-63.
12. Dillon MJ, Barratt TM, Sabbagh PA, et al. Plasma-exchange in children: results in vasculitis and haemolytic uraemic syndrome. In: Murakami K, Kitegawa T, Yabuta K, Sakai T, eds. Recent advances in pediatric nephrology. Amsterdam: Excerpta Medica, 1987: 447-52.
13. Walters MDS, Savage COS, Dillon MJ, Lockwood CM, Barrait TM. Antineutrophil cytoplasm antibody in crescentic glomerulonephritis. Arch Dis Child 1988; 63: 814-7.
14. Tizard EJ, Dillon MJ. Plasmapheresis in childhood. Care of the Critically III 1991; 7: 51-5.
15. Jardim HMPF, Leake J, Risdon RA, Barratt TM, Dillon MJ. Crescentic glomerulonephritis in children. Pediatr Nephrol 1992; 6: 231-5.
16. Jordan SC, Ho W, Ettenger R, Salusky IB, Fine RN. Plasma exchange improves the glomerulonephritis of systemic lupus erythematosus in selected pediatric patients. Pediatr Nephrol 1987; 1: 276-80.
17. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
18. Lighfoot RW, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-93.
19. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
20. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33:1114-21.
21. Counahan R, Winterborn MH, White RHR, et al. Prognosis of Henoch-Schönlein nephritis in children. BMJ 1977; 2: 11-4.
22. Niaudet P, Levy M. Glomerulonephrites a croissants diffus. In: Royer P, Habib R, Mathieu H, Broyer M, eds. Nephrologie pediatrique. Flammarion, 1983: 381-94.
23. Pohl MA, Lan SP, Berl T, and the Lupus Nephritis Collaborative Study Group. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. Ann Intern Med 1991; 114: 924-9.